Tata Consultancy Services (NSE:TCS, BOM:532540) launched TCS ADD AgentHub, an artificial intelligence platform to help pharmaceutical companies use AI in clinical trials and drug safety processes.
The platform supports workflows including clinical data management, study design, data review and pharmacovigilance, with built-in oversight and audit controls for regulatory requirements, according to an Indian bourse filing on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.